ALNYLAM PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Tax Withholding Paid on Stock Awards of $84.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2019-08-06
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2019-06-30 was $32.00K, a 46.67% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2019-03-31 was $52.00K, a 90.91% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-12-31 was $2.29M, a 3223.19% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-09-30 was $544.00K, a 1226.83% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2018 was $3.47M, a 1249.81% increase from fiscal 2017.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2017 was $257.00K, a 56.88% decline from fiscal 2016.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2016 was $596.00K, a 57.67% increase from fiscal 2015.
- ALNYLAM PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2015 was $378.00K, a 97.64% decline from fiscal 2014.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2019-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $84.00K 10-Q · filed 2019-08-06 | $2.38M derived: sum of 3 quarters · filed 2019-08-06 | $2.92M derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | $52.00K 10-Q · filed 2019-05-02 | $2.35M derived: sum of 2 quarters · filed 2019-05-02 | $2.89M derived: sum of 3 quarters · filed 2019-05-02 | $2.95M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $2.84M derived: sum of 2 quarters · filed 2019-02-14 | $2.90M derived: sum of 3 quarters · filed 2019-08-06 | $3.47M 10-K · filed 2019-02-14 |
| 2018-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $604.00K derived: sum of 2 quarters · filed 2019-08-06 | $1.18M 10-Q · filed 2018-11-07 | $1.25M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $632.00K 10-Q · filed 2019-08-06 | $701.00K derived: sum of 3 quarters · filed 2019-08-06 | $742.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $572.00K 10-Q · filed 2019-05-02 | $641.00K derived: sum of 2 quarters · filed 2019-05-02 | $682.00K derived: sum of 3 quarters · filed 2019-05-02 | $776.00K derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $110.00K derived: sum of 2 quarters · filed 2019-02-14 | $204.00K derived: sum of 3 quarters · filed 2019-02-14 | $257.00K 10-K · filed 2019-02-14 |
| 2017-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $135.00K derived: sum of 2 quarters · filed 2018-11-07 | $188.00K 10-Q · filed 2018-11-07 | $543.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $147.00K 10-Q · filed 2018-08-02 | $502.00K derived: sum of 3 quarters · filed 2019-02-14 | $580.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $53.00K 10-Q · filed 2018-05-04 | $408.00K derived: sum of 2 quarters · filed 2019-02-14 | $486.00K derived: sum of 3 quarters · filed 2019-02-14 | $590.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $433.00K derived: sum of 2 quarters · filed 2019-02-14 | $537.00K derived: sum of 3 quarters · filed 2019-02-14 | $596.00K 10-K · filed 2019-02-14 |
| 2016-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $182.00K derived: sum of 2 quarters · filed 2017-11-07 | $241.00K 10-Q · filed 2017-11-07 | $316.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $163.00K 10-Q · filed 2017-08-09 | $238.00K derived: sum of 3 quarters · filed 2018-02-15 | $418.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $59.00K 10-Q · filed 2017-05-05 | $134.00K derived: sum of 2 quarters · filed 2018-02-15 | $314.00K derived: sum of 3 quarters · filed 2018-02-15 | |
| 2015-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $255.00K derived: sum of 2 quarters · filed 2018-02-15 | $378.00K 10-K · filed 2018-02-15 | |
| 2015-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $303.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $123.00K 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $289.00K derived: sum of 2 quarters · filed 2017-02-15 | $289.00K derived: sum of 3 quarters · filed 2017-02-15 | $15.99M 10-K · filed 2017-02-15 |
| 2014-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $262.00K derived: sum of 2 quarters · filed 2015-11-09 | $15.96M 10-Q · filed 2015-11-09 | $17.24M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $15.70M 10-Q · filed 2015-08-07 | $16.98M derived: sum of 3 quarters · filed 2016-02-12 | |
| 2014-03-31 | $15.70M 10-Q · filed 2015-05-08 | $16.98M derived: sum of 2 quarters · filed 2016-02-12 | ||
| 2013-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $1.39M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | $115.00K 10-Q · filed 2014-11-06 | |||
| 2012-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $31.00K derived: sum of 2 quarters · filed 2015-02-13 | $359.00K 10-K · filed 2015-02-13 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $328.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $328.00K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |